LY3164530

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3164530, covering 2019-10-23 to 2019-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3164530 in Participants With Cancer [Phase 1]